{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:54:45Z","timestamp":1785214485615,"version":"3.55.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,7]],"date-time":"2027-01-07T00:00:00Z","timestamp":1799280000000},"content-version":"am","delay-in-days":312,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20 GM103427"],"award-info":[{"award-number":["P20 GM103427"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006518","name":"University of Nebraska Medical Center","doi-asserted-by":"publisher","award":["P30 GM127200"],"award-info":[{"award-number":["P30 GM127200"]}],"id":[{"id":"10.13039\/100006518","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006518","name":"University of Nebraska Medical Center","doi-asserted-by":"publisher","award":["R01 CA235863"],"award-info":[{"award-number":["R01 CA235863"]}],"id":[{"id":"10.13039\/100006518","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006518","name":"University of Nebraska Medical Center","doi-asserted-by":"publisher","award":["R01 DK124095"],"award-info":[{"award-number":["R01 DK124095"]}],"id":[{"id":"10.13039\/100006518","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006518","name":"University of Nebraska Medical Center","doi-asserted-by":"publisher","award":["R01 DK120533"],"award-info":[{"award-number":["R01 DK120533"]}],"id":[{"id":"10.13039\/100006518","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK120533"],"award-info":[{"award-number":["R01 DK120533"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA235863"],"award-info":[{"award-number":["R01 CA235863"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 GM127200"],"award-info":[{"award-number":["P30 GM127200"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK124095"],"award-info":[{"award-number":["R01 DK124095"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016764","name":"Fred and Pamela Buffett Cancer Center","doi-asserted-by":"publisher","award":["P30 CA036727"],"award-info":[{"award-number":["P30 CA036727"]}],"id":[{"id":"10.13039\/100016764","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jconrel.2025.114570","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:07:57Z","timestamp":1766534877000},"page":"114570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Inhalable perfluorocarbon RNA nanocapsules overcome biological barriers to treat lung metastases"],"prefix":"10.1016","volume":"391","author":[{"given":"Kasturi","family":"Siddhanta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atefehsadat","family":"Monirvaghefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Braeden R.","family":"Pinkerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.","family":"Woslager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjina Akter","family":"Kalpana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinmay M.","family":"Jogdeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley R.","family":"Ravnholdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill A.","family":"Poole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua L.","family":"Santarpia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Talmadge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Oupick\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jconrel.2025.114570_bb0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/pharmaceutics13020177","article-title":"Inhaled RNA therapeutics for obstructive airway diseases: recent advances and future prospects","volume":"13","author":"Xu","year":"2021","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.jconrel.2025.114570_bb0010","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1021\/ar200110p","article-title":"Nonviral pulmonary delivery of siRNA","volume":"45","author":"Merkel","year":"2012","journal-title":"Acc. Chem. Res."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114570_bb0015","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1365-2125.2003.01892.x","article-title":"Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications","volume":"56","author":"Labiris","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.jconrel.2025.114570_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10092179","article-title":"Lipid nanoparticles as delivery vehicles for inhaled therapeutics","volume":"10","author":"Leong","year":"2022","journal-title":"Biomedicines"},{"issue":"23","key":"10.1016\/j.jconrel.2025.114570_bb0025","doi-asserted-by":"crossref","first-page":"25106","DOI":"10.1021\/acsomega.4c02324","article-title":"Optimal treatment of tumor in upper human respiratory tract using microaerosols","volume":"9","author":"Riaz","year":"2024","journal-title":"ACS Omega"},{"issue":"9","key":"10.1016\/j.jconrel.2025.114570_bb0030","doi-asserted-by":"crossref","first-page":"14792","DOI":"10.1021\/acsnano.2c05647","article-title":"Engineering lipid nanoparticles for enhanced intracellular delivery of mRNA through inhalation","volume":"16","author":"Kim","year":"2022","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.jconrel.2025.114570_bb0035","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/s41565-023-01548-3","article-title":"Combinatorial development of nebulized mRNA delivery formulations for the lungs","volume":"19","author":"Jiang","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.114570_bb0040","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jconrel.2023.09.031","article-title":"Spray dried lipid nanoparticle formulations enable intratracheal delivery of mRNA","volume":"363","author":"Friis","year":"2023","journal-title":"J. Control. Release"},{"issue":"17","key":"10.1016\/j.jconrel.2025.114570_bb0045","doi-asserted-by":"crossref","first-page":"11335","DOI":"10.1021\/acsnano.4c00768","article-title":"Microfluidic platform enables shearless aerosolization of lipid nanoparticles for mRNA inhalation","volume":"18","author":"Kim","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114570_bb0050","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jconrel.2020.11.005","article-title":"Pulmonary siRNA delivery for lung disease: review of recent progress and challenges","volume":"330","author":"Ding","year":"2021","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.jconrel.2025.114570_bb0055","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/mt.2010.282","article-title":"Mechanistically probing lipid-siRNA nanoparticle-associated toxicities identifies Jak inhibitors effective in mitigating multifaceted toxic responses","volume":"19","author":"Tao","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.114570_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2018.01.001","article-title":"A comparison of the lung clearance kinetics of solid lipid nanoparticles and liposomes by following the 3H-labelled structural lipids after pulmonary delivery in rats","volume":"125","author":"Haque","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114570_bb0065","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/aps.2017.34","article-title":"Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities","volume":"38","author":"Mangal","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"issue":"11","key":"10.1016\/j.jconrel.2025.114570_bb0070","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1080\/08958370290084809","article-title":"Aerosol transport and deposition in a triple bifurcation bronchial airway model with local tumors","volume":"14","author":"Zhang","year":"2002","journal-title":"Inhal. Toxicol."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114570_bb0075","doi-asserted-by":"crossref","DOI":"10.29245\/2689-999X\/2019\/2.1148","article-title":"Pulmonary nano-drug delivery systems for lung cancer: current knowledge and prospects","volume":"3","author":"Amararathna","year":"2019","journal-title":"J. Lung Health Dis."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114570_bb0080","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1080\/10717544.2021.1981492","article-title":"Surface-engineered smart nanocarrier-based inhalation formulations for targeted lung cancer chemotherapy: a review of current practices","volume":"28","author":"Yu","year":"2021","journal-title":"Drug Deliv."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114570_bb0085","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jconrel.2013.09.013","article-title":"Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles","volume":"172","author":"Ernsting","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114570_bb0090","article-title":"Engineering tumor-targeting nanoparticles as vehicles for precision nanomedicine","volume":"4","author":"Gonda","year":"2019","journal-title":"Med One"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2025.114570_bb0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/10731199709118896","article-title":"Advanced fluorocarbon-based systems for oxygen and drug delivery, and diagnosis","volume":"25","author":"Riess","year":"1997","journal-title":"Artif. Cells Blood Subst. Biotechnol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114570_bb0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1081\/BIO-200046659","article-title":"Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery","volume":"33","author":"Riess","year":"2005","journal-title":"Artif. Cells Blood Subst. Biotechnol."},{"issue":"9","key":"10.1016\/j.jconrel.2025.114570_bb0105","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/jps.1086","article-title":"Use of perfluorocarbon (Fluorinert) to enhance reporter gene expression following intratracheal instillation into the lungs of Balb\/c mice: implications for nebulized delivery of plasmids","volume":"90","author":"Das","year":"2001","journal-title":"J. Pharm. Sci."},{"issue":"14","key":"10.1016\/j.jconrel.2025.114570_bb0110","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1089\/10430349950016933","article-title":"Perflubron enhances adenovirus-mediated gene expression in lungs of transgenic mice with chronic alveolar filling","volume":"10","author":"Weiss","year":"1999","journal-title":"Hum. Gene Ther."},{"issue":"8","key":"10.1016\/j.jconrel.2025.114570_bb0115","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1089\/hum.1997.8.8-919","article-title":"Enhanced distribution of adenovirus-mediated gene transfer to lung parenchyma by perfluorochemical liquid","volume":"8","author":"Lisby","year":"1997","journal-title":"Hum. Gene Ther."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114570_bb0120","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.57.3.263","article-title":"Effect of fluorocarbon liquid on surface tension properties of pulmonary surfactant","volume":"57","author":"Modell","year":"1970","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.jconrel.2025.114570_bb0125","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1152\/jappl.2001.90.3.839","article-title":"Effects of perfluorochemical distribution and elimination dynamics on cardiopulmonary function","volume":"90","author":"Miller","year":"2001","journal-title":"J. Appl. Physiol."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114570_bb0130","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1378\/chest.119.2.515","article-title":"The pulmonary and systemic distribution and elimination of perflubron from adult patients treated with partial liquid ventilation","volume":"119","author":"Reickert","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.jconrel.2025.114570_bb0135","series-title":"Perflubron Enhances Mucin Plug Clearance In Vitro in the Presence of Natural Surfactant","author":"Al-Saiedy","year":"2013"},{"issue":"10","key":"10.1016\/j.jconrel.2025.114570_bb0140","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1021\/acs.nanolett.6b02365","article-title":"Ultrasound triggered tumor oxygenation with oxygen-shuttle nanoperfluorocarbon to overcome hypoxia-associated resistance in cancer therapies","volume":"16","author":"Song","year":"2016","journal-title":"Nano Lett."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114570_bb0145","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1586\/17476348.2.2.273","article-title":"Anti-inflammatory effects of perfluorocarbon compounds","volume":"2","author":"Lehmler","year":"2008","journal-title":"Expert Rev. Respir. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114570_bb0150","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1203\/00006450-200202000-00010","article-title":"Partial liquid ventilation reduces release of leukotriene B4 and interleukin-6 in bronchoalveolar lavage in surfactant-depleted newborn pigs","volume":"51","author":"Merz","year":"2002","journal-title":"Pediatr. Res."},{"issue":"5","key":"10.1016\/j.jconrel.2025.114570_bb0155","doi-asserted-by":"crossref","first-page":"L1018","DOI":"10.1152\/ajplung.2000.278.5.L1018","article-title":"In vitro cellular effects of perfluorochemicals correlate with their lipid solubility","volume":"278","author":"Obraztsov","year":"2000","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"5","key":"10.1016\/j.jconrel.2025.114570_bb0160","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00024382-199611000-00007","article-title":"Perfluorocarbon protects lung epithelial cells from neutrophil-mediated injury in an in vitro model of liquid ventilation therapy","volume":"6","author":"Varani","year":"1996","journal-title":"Shock"},{"issue":"4","key":"10.1016\/j.jconrel.2025.114570_bb0165","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/00003246-200004000-00034","article-title":"Perfluorocarbon blocks tumor necrosis factor-\u03b1-induced interleukin-8 release from alveolar epithelial cells in vitro","volume":"28","author":"Baba","year":"2000","journal-title":"Crit. Care Med."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114570_bb0170","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000097130","article-title":"Perfluorocarbon suppresses lipopolysaccharide-and \u03b1-toxin-induced interleukin-8 release from alveolar epithelial cells","volume":"91","author":"Nakata","year":"2007","journal-title":"Neonatology"},{"issue":"5","key":"10.1016\/j.jconrel.2025.114570_bb0175","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1021\/la104221q","article-title":"How to prepare and stabilize very small nanoemulsions","volume":"27","author":"Delmas","year":"2011","journal-title":"Langmuir"},{"issue":"7","key":"10.1016\/j.jconrel.2025.114570_bb0180","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1039\/C5BM00003C","article-title":"Balancing polymer hydrophobicity for ligand presentation and siRNA delivery in dual function CXCR4 inhibiting polyplexes","volume":"3","author":"Wang","year":"2015","journal-title":"Biomater. Sci."},{"issue":"8","key":"10.1016\/j.jconrel.2025.114570_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202103676","article-title":"Perfluorocarbon nanoemulsions enhance therapeutic siRNA delivery in the treatment of pulmonary fibrosis","volume":"9","author":"Ding","year":"2022","journal-title":"Adv. Sci."},{"issue":"23","key":"10.1016\/j.jconrel.2025.114570_bb0190","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.1158\/0008-5472.CAN-04-1844","article-title":"CXCR4 regulates growth of both primary and metastatic breast cancer","volume":"64","author":"Smith","year":"2004","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114570_bb0195","doi-asserted-by":"crossref","first-page":"641a","DOI":"10.1016\/j.bpj.2015.11.3431","article-title":"CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM simulations using the CHARMM36 additive force field","volume":"110","author":"Lee","year":"2016","journal-title":"Biophys. J."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114570_bb0200","doi-asserted-by":"crossref","DOI":"10.1088\/0965-0393\/18\/1\/015012","article-title":"Visualization and analysis of atomistic simulation data with OVITO\u2013the open visualization tool","volume":"18","author":"Stukowski","year":"2009","journal-title":"Model. Simul. Mater. Sci. Eng."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114570_bb0205","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3390\/diagnostics13010165","article-title":"Oncologic outcome after pulmonary metastasectomy as part of multidisciplinary treatment in a tertiary oncological center","volume":"13","author":"Motas","year":"2023","journal-title":"Diagnostics"},{"issue":"4","key":"10.1016\/j.jconrel.2025.114570_bb0210","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1677\/erc.0.0070271","article-title":"Mechanisms in the skeletal complications of breast cancer","volume":"7","author":"Martin","year":"2000","journal-title":"Endocr. Relat. Cancer"},{"issue":"6","key":"10.1016\/j.jconrel.2025.114570_bb0215","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ejcts.2008.07.063","article-title":"Pulmonary metastases of breast cancer. When is resection indicated?","volume":"34","author":"Welter","year":"2008","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"8","key":"10.1016\/j.jconrel.2025.114570_bb0220","first-page":"1441","article-title":"Prognostic factors for resection of isolated pulmonary metastases in breast cancer patients: a systematic review and meta-analysis","volume":"7","author":"Fan","year":"2015","journal-title":"J. Thorac. Dis."},{"issue":"21","key":"10.1016\/j.jconrel.2025.114570_bb0225","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1016\/j.biomaterials.2014.03.047","article-title":"Effect of biodegradability on CXCR4 antagonism, transfection efficacy and antimetastatic activity of polymeric plerixafor","volume":"35","author":"Li","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114570_bb0230","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jconrel.2021.03.028","article-title":"Polycation fluorination improves intraperitoneal siRNA delivery in metastatic pancreatic cancer","volume":"333","author":"Hang","year":"2021","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.jconrel.2025.114570_bb0235","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1021\/bc0340565","article-title":"Modified linear polyethylenimine\u2212cholesterol conjugates for DNA complexation","volume":"14","author":"Furgeson","year":"2003","journal-title":"Bioconjug. Chem."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114570_bb0240","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1021\/bm025563c","article-title":"Novel branched poly (ethylenimine)\u2212cholesterol water-soluble lipopolymers for gene delivery","volume":"3","author":"Wang","year":"2002","journal-title":"Biomacromolecules"},{"issue":"10","key":"10.1016\/j.jconrel.2025.114570_bb0245","doi-asserted-by":"crossref","first-page":"13569","DOI":"10.1021\/acsnano.0c05617","article-title":"Perfluorocarbon@ porphyrin nanoparticles for tumor hypoxia relief to enhance photodynamic therapy against liver metastasis of colon cancer","volume":"14","author":"Liang","year":"2020","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.jconrel.2025.114570_bb0250","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.bpj.2022.03.032","article-title":"RNA at the surface of phase-separated condensates impacts their size and number","volume":"121","author":"Cochard","year":"2022","journal-title":"Biophys. J."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114570_bb0255","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/hum.1997.8.3-313","article-title":"Optimization of formulations and conditions for the aerosol delivery of functional cationic lipid: DNA complexes","volume":"8","author":"Eastman","year":"1997","journal-title":"Hum. Gene Ther."},{"issue":"52","key":"10.1016\/j.jconrel.2025.114570_bb0260","doi-asserted-by":"crossref","first-page":"31027","DOI":"10.1039\/D0RA04088F","article-title":"The effect of surfactants on hydrate particle agglomeration in liquid hydrocarbon continuous systems: a molecular dynamics simulation study","volume":"10","author":"Fang","year":"2020","journal-title":"RSC Adv."},{"issue":"23","key":"10.1016\/j.jconrel.2025.114570_bb0265","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1021\/acs.jpcb.1c01148","article-title":"Analyzing the role of surfactants in the colloidal stability of nanoparticles in oil through coarse-grained molecular dynamics simulations","volume":"125","author":"Griffiths","year":"2021","journal-title":"J. Phys. Chem. B."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114570_bb0270","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/hep.27378","article-title":"Tissue inhibitor of metalloproteinases (TIMP)-1 creates a premetastatic niche in the liver through SDF-1\/CXCR4-dependent neutrophil recruitment in mice","volume":"61","author":"Seubert","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2025.114570_bb0275","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3389\/fimmu.2020.00407","article-title":"Inhibition of CXCR4 and CXCR7 is protective in acute peritoneal inflammation","volume":"11","author":"Ngamsri","year":"2020","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.jconrel.2025.114570_bb0280","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.ATV.17.9.1837","article-title":"Expression of matrix metalloproteinases and their inhibitor TIMP-1 in the rat carotid artery after balloon injury","volume":"17","author":"Webb","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.jconrel.2025.114570_bb0285","first-page":"L946","article-title":"Clathrin-mediated endocytosis of FITC-albumin in alveolar type II epithelial cell line RLE-6TN","volume":"290","author":"Yumoto","year":"2006","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114570_bb0290","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2217\/nnm-2016-0332","article-title":"The glycocalyx regulates the uptake of nanoparticles by human endothelial cells in vitro","volume":"12","author":"M\u00f6ckl","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2025.114570_bb0295","first-page":"1","article-title":"MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer","volume":"38","author":"Zhang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114570_bb0300","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s11033-022-08047-z","article-title":"p53 downregulates PD-L1 expression via miR-34a to inhibit the growth of triple-negative breast cancer cells: a potential clinical immunotherapeutic target","volume":"50","author":"Deng","year":"2023","journal-title":"Mol. Biol. Rep."},{"issue":"10","key":"10.1016\/j.jconrel.2025.114570_bb0305","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1073\/pnas.1815515116","article-title":"Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer","volume":"116","author":"Chen","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.jconrel.2025.114570_bb0310","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2613.2007.00539.x","article-title":"The mouse mammary carcinoma 4T1: characterization of the cellular landscape of primary tumours and metastatic tumour foci","volume":"88","author":"DuPr\u00e9","year":"2007","journal-title":"Int. J. Exp. Pathol."},{"issue":"10","key":"10.1016\/j.jconrel.2025.114570_bb0315","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1084\/jem.20042307","article-title":"The macrophage F4\/80 receptor is required for the induction of antigen-specific efferent regulatory T cells in peripheral tolerance","volume":"201","author":"Lin","year":"2005","journal-title":"J. Exp. Med."},{"issue":"13","key":"10.1016\/j.jconrel.2025.114570_bb0320","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1158\/1078-0432.CCR-19-0081","article-title":"Mobilization of CD8+ T cells via CXCR4 blockade facilitates PD-1 checkpoint therapy in human pancreatic cancer","volume":"25","author":"Seo","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"21","key":"10.1016\/j.jconrel.2025.114570_bb0325","doi-asserted-by":"crossref","first-page":"8368","DOI":"10.1158\/0008-5472.CAN-10-1322","article-title":"CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes","volume":"70","author":"Bos","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114570_bb0330","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/bs.acr.2015.04.002","article-title":"Myeloid-derived suppressor cells: critical cells driving immune suppression in the tumor microenvironment","volume":"128","author":"Parker","year":"2015","journal-title":"Adv. Cancer Res."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114570_bb0335","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41419-021-04487-w","article-title":"The downregulation of type I IFN signaling in G-MDSCs under tumor conditions promotes their development towards an immunosuppressive phenotype","volume":"13","author":"Sun","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2025.114570_bb0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-021-01156-5","article-title":"Modulating tumor infiltrating myeloid cells to enhance bispecific antibody-driven T cell infiltration and anti-tumor response","volume":"14","author":"Park","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"7","key":"10.1016\/j.jconrel.2025.114570_bb0345","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126853","article-title":"Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy","volume":"4","author":"Sun","year":"2019","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.jconrel.2025.114570_bb0350","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1158\/0008-5472.CAN-11-1977","article-title":"Tumor suppressive microRNAs miR-34a\/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D","volume":"72","author":"Heinemann","year":"2012","journal-title":"Cancer Res."},{"issue":"50","key":"10.1016\/j.jconrel.2025.114570_bb0355","doi-asserted-by":"crossref","first-page":"21248","DOI":"10.1073\/pnas.1015855107","article-title":"Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+ Ly6C+ granulocytes","volume":"107","author":"Kowanetz","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"10","key":"10.1016\/j.jconrel.2025.114570_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.xgen.2024.100659","article-title":"CXCR4 orchestrates the TOX-programmed exhausted phenotype of CD8+ T cells via JAK2\/STAT3 pathway","volume":"4","author":"Cao","year":"2024","journal-title":"Cell Genomics"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925011848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925011848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:33:49Z","timestamp":1781771629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925011848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":72,"alternative-id":["S0168365925011848"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114570","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhalable perfluorocarbon RNA nanocapsules overcome biological barriers to treat lung metastases","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114570","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114570"}}